Odyssey Thera Awarded 19th Patent for Drug Discovery and Re-Purposing Technologies
News May 09, 2011
Odyssey Thera, Inc. has announced that the United States Patent and Trademark Office granted U.S. Patent No. 7,935,493, entitled "Protein fragment complementation assays for high-throughput and high-content screening."
Claims granted in the patent broadly cover the application of contextual high-content assays to diverse biological events, and the use of these methods for novel drug discovery and drug re-indication.
The concept of utilizing drugs with well-established pharmacology and safety characteristics for a novel therapeutic focus - drug re-indication or "re-repurposing" - has been proposed as a solution for improving success rates of therapeutic development.
"This patent, in concert with our existing IP, provides unprecedented coverage of cellular signaling space," said John K. Westwick, Ph.D., Odyssey Thera President and CEO.
"Access to all target classes and pathways is essential for deciphering compound and target mechanisms. Technologies protected by this patent, combined with our proprietary strategies for expediting preclinical development, represent a unique platform for fast-tracking new therapeutic development."
A team of researchers has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.READ MORE
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.READ MORE
2nd AI Pharma Innovation: Drug Discovery 2019 Summit
Feb 27 - Feb 28, 2019
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
14th World Congress on Medicinal Chemistry and Drug Design
Jun 10 - Jun 11, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019